Literature DB >> 20531048

Resolution of statin-induced myalgias by correcting vitamin D deficiency.

David S H Bell1.   

Abstract

Correction of hyperlipidemia with statins is often limited by the side-effect of statin-induced myalgias. Vitamin D deficiency is also associated with myalgias that resolve with correction of the vitamin D deficiency. Myalgias associated with statin therapy may also resolve with correction of vitamin D deficiency. This case report presents a case where cardioprotective lipid levels were achieved with a powerful statin only after correction of vitamin D deficiency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20531048     DOI: 10.1097/SMJ.0b013e3181e21088

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  9 in total

Review 1.  The effects of statin medications on aerobic exercise capacity and training adaptations.

Authors:  Zsolt Murlasits; Zsolt Radák
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

2.  Vitamin d and cardiovascular disease.

Authors:  Jacqueline S Danik; Joann E Manson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

Review 3.  The Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination Therapy.

Authors:  Richard E Deichmann; Carl J Lavie; Timothy Asher; James J DiNicolantonio; James H O'Keefe; Paul D Thompson
Journal:  Ochsner J       Date:  2015

4.  Effect of vitamin D on bioavailability and lipid lowering efficacy of simvastatin.

Authors:  Abdulrahman K Al-Asmari; Zabih Ullah; Fahad Al-Sabaan; Mohammad Tariq; Ahmed Al-Eid; Saud F Al-Omani
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-04-18       Impact factor: 2.441

5.  Statin Intolerance Because of Myalgia, Myositis, Myopathy, or Myonecrosis Can in Most Cases be Safely Resolved by Vitamin D Supplementation.

Authors:  Maksim Khayznikov; Kallish Hemachrandra; Ramesh Pandit; Ashwin Kumar; Ping Wang; Charles J Glueck
Journal:  N Am J Med Sci       Date:  2015-03

Review 6.  Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.

Authors:  Pierandrea Vinci; Emiliano Panizon; Letizia Maria Tosoni; Carla Cerrato; Federica Pellicori; Filippo Mearelli; Chiara Biasinutto; Nicola Fiotti; Filippo Giorgio Di Girolamo; Gianni Biolo
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

7.  Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approach.

Authors:  Hilda J I de Jong; Siti R F Saldi; Olaf H Klungel; Rob J Vandebriel; Patrick C Souverein; Ronald H B Meyboom; J L M Anneke Passier; Henk van Loveren; Jan Willem Cohen Tervaert
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

8.  Safety of 50,000-100,000 Units of Vitamin D3/Week in Vitamin D-Deficient, Hypercholesterolemic Patients with Reversible Statin Intolerance.

Authors:  Vybhav Jetty; Charles J Glueck; Ping Wang; Parth Shah; Marloe Prince; Kevin Lee; Michael Goldenberg; Ashwin Kumar
Journal:  N Am J Med Sci       Date:  2016-03

9.  Myopathy induced by statin-ezetimibe combination: Evaluation of potential risk factors.

Authors:  Ballari Brahmachari; Suparna Chatterjee
Journal:  Indian J Pharmacol       Date:  2015 Sep-Oct       Impact factor: 1.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.